Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA approval
Pharma
Roche’s Gazyva wins first FDA nod for membranous nephropathy
Besides lupus nephritis, idiopathic nephrotic syndrome and membranous nephropathy, Gazyva also awaits an FDA decision in systemic lupus erythematosus.
Angus Liu
Nov 16, 2026 11:00am
AZ beefs up myasthenia gravis pedigree with US, EU Klygefa nods
Nov 16, 2026 10:39am
AZ's Imfinzi keeps MIBC race against Keytruda hot with FDA nod
Nov 13, 2026 5:40pm
Orzeyful gets off to races in US with 'lighter' DEA schedule
Nov 12, 2026 11:16am
Merck KGaA's Pimjetmi wins FDA approval in rare tumor disorder
Nov 10, 2026 5:45pm
Bayer nabs 1st-in-class FDA nod for stroke med asundexian
Nov 9, 2026 9:10pm